METACARE CO., Ltd. (KRX:118000)
South Korea · Delayed Price · Currency is KRW 223.00
0.00 (0.00%)
At close: Apr 8, 2026
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 38.31 billion as of April 8, 2026. Its market cap has decreased by -21.46% in one year.
Market Cap
38.31B
Enterprise Value
97.37B
Revenue
32.82B
Ranking
n/a
PE Ratio
74.33
Stock Price
223.00
Market Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has decreased from 39.82B to 38.31B, a decrease of -3.79%. That is a compound annual growth rate of -0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 38.31B | -26.89% |
| Dec 30, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.94T |
| Celltrion | 42.71T |
| ALTEOGEN | 19.56T |
| Sam Chun Dang Pharm. | 15.07T |
| HASS Corp. | 55.92B |
| Aprogen Biologics | 52.75B |
| EOFLOW | 51.11B |
| IVIM Technology | 49.44B |